Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma
Cells lacking the tumor suppressor gene alter their metabolism to match the demands of accelerated growth, leaving them highly vulnerable to stress. However, targeted therapy for LKB1-deficient cancers has yet to be reported. In both cell lines and a genetically engineered mouse model of -induced lu...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 77; no. 18; pp. 5068 - 5076 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Association for Cancer Research, Inc
15.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!